Attached files

file filename
8-K - FORM 8-K FILING DOCUMENT - EXPONENT INCdocument.htm

EXHIBIT 99.1

Exponent Reports Strong Second Quarter 2011 Results

MENLO PARK, Calif., July 20, 2011 (GLOBE NEWSWIRE) -- Exponent, Inc. (Nasdaq:EXPO) today reported financial results for the second quarter and six months ended July 1, 2011.

For the second quarter of 2011, total revenues increased 8% to $65,106,000, as compared to $60,439,000 in the same period one year ago. Revenues before reimbursements increased 10% to $60,573,000, as compared to $55,128,000 in the second quarter of 2010.  

Net income for the quarter was up 13% to $8,217,000, or $0.55 per diluted share, as compared to $7,280,000, or $0.48 per diluted share, reported in the same quarter a year ago. EBITDA1 improved 13% to $14,987,000, as compared to $13,293,000 in the second quarter last year.

During the second quarter of 2011, Exponent repurchased $16 million of its common stock, bringing the 2011 year-to-date repurchase total to $23 million. The Company closed the second quarter with $95 million in cash, cash equivalents and short-term investments.

For the first half of 2011, total revenues increased 16% to $138,579,000, as compared to $119,845,000 in the same period of last year. Revenues before reimbursements increased 13% to $124,756,000, as compared to $110,329,000 in the same period of 2010. 

Net income for the first half of 2011 improved 20% to $16,220,000, or $1.08 per diluted share, as compared to $13,519,000, or $0.90 per diluted share, reported in the prior year period. EBITDA1 in the first half of 2011 improved 18% to $29,409,000, as compared to $24,833,000 in the first half of 2010.

"We are pleased with our performance in the quarter, showing continued revenue growth and profitability," commented Dr. Paul Johnston, President and CEO. "Our utilization remained strong as we experienced sustained demand related to a few major assignments. We had notable contributions from our mechanics and materials, electrical, thermal sciences, and human factors practices. 

"Looking forward, we are mindful of the comparison against an unusually strong second half of 2010, where utilization and product sales were significantly higher than historical levels. Nevertheless, given our strong performance in the first half of 2011, we are now raising our full-year expectations for EBITDA1 margin to be only slightly down and for growth in revenue before reimbursements to be in the high single digits, as compared to 2010. 

"We added key talent in the quarter, expanding our breadth of disciplines and depth of knowledge in engineering and science. Our professionals continue to demonstrate the appropriate expertise and experience to answer clients' important technology, health, and environmental questions," concluded Dr. Johnston.

Today's Conference Call Information

Exponent will discuss its financial results in more detail on a conference call today, July 20, 2011, starting at 4:30 p.m. Eastern Time/1:30 p.m. Pacific Time. The audio on the conference call is available by dialing 877-941-2068 or 480-629-9712. A live webcast of the call will be available on the Investor Relations section of the Company's website at www.exponent.com/investors. For those unable to listen to the live webcast, a replay of the call will also be available on the Exponent web site, or by dialing 800-406-7325 or 303-590-3030, and entering reservation 4456038#.

About Exponent

Exponent is an engineering and scientific consulting firm providing solutions to complex problems. Exponent's multidisciplinary organization of scientists, physicians, engineers, and business consultants brings together more than 90 technical disciplines to address complicated issues facing industry and government today. The firm has been best known for analyzing accidents and failures to determine their causes, but in recent years it has become more active in assisting clients with human health, environmental and engineering issues associated with new products to help prevent problems in the future.

Exponent may be reached at (888) 656-EXPO, info@exponent.com, or www.exponent.com.

This news release contains, and incorporates by reference, certain "forward-looking" statements (as such term is defined in the Private Securities Litigation Reform Act of 1995, and the rules promulgated pursuant to the Securities Act of 1933, as amended, and the Securities Exchange Act of 1934, as amended thereto under) that are based on the beliefs of the Company's management, as well as assumptions made by and information currently available to the Company's management. Such forward-looking statements are subject to the safe harbor created by the Private Securities Litigation Reform Act of 1995. When used in this document and in the documents incorporated herein by reference, the words "anticipate," "believe," "estimate," "expect" and similar expressions, as they relate to the Company or its management, identify such forward-looking statements. Such statements reflect the current views of the Company or its management with respect to future events and are subject to certain risks, uncertainties and assumptions. Should one or more of these risks or uncertainties materialize, or should underlying assumptions prove incorrect, the Company's actual results, performance, or achievements could differ materially from those expressed in, or implied by, any such forward-looking statements. Factors that could cause or contribute to such material differences include the possibility that the demand for our services may decline as a result of changes in general and industry specific economic conditions, the timing of engagements for our services, the effects of competitive services and pricing, the absence of backlog related to our business, our ability to attract and retain key employees, the effect of tort reform and government regulation on our business, and liabilities resulting from claims made against us. Additional risks and uncertainties are discussed in our Annual Report on Form 10-K under the heading "Risk Factors" and elsewhere in the report. The inclusion of such forward-looking information should not be regarded as a representation by the Company or any other person that the future events, plans, or expectations contemplated by the Company will be achieved. The Company undertakes no obligation to release publicly any updates or revisions to any such forward-looking statements.

1 EBITDA is a non-GAAP financial measure defined by the Company as net income before income taxes, interest income, depreciation and amortization. EBITDAS is a non-GAAP financial measure defined by the Company as EBITDA before stock-based compensation. The Company regards EBITDA and EBITDAS as useful measures of operating performance and cash flow to complement operating income, net income and other GAAP financial performance measures. Additionally, management believes that EBITDA and EBITDAS provide meaningful comparisons of past, present and future operating results. Generally, a non-GAAP financial measure is a numerical measure of a company's performance, financial position or cash flow that either excludes or includes amounts that are not normally excluded or included in the most directly comparable measure calculated and presented in accordance with GAAP. These measures, however, should be considered in addition to, and not as a substitute or superior to, operating income, cash flows, or other measures of financial performance prepared in accordance with GAAP. A reconciliation of the measures to GAAP is set forth below.

EXPONENT, INC. 
CONDENSED CONSOLIDATED STATEMENTS OF INCOME
For the Quarters Ended July 1, 2011 and July 2, 2010
(unaudited)
(in thousands, except per share data)
         
     
   Quarter Ended   Six Months Ended 
  July 1,
2011
July 2,
2010
July 1,
2011
July 2, 
2010
Revenues        
Revenues before reimbursements  $ 60,573  $ 55,128  $ 124,756  $ 110,329
Reimbursements  4,533  5,311  13,823  9,516
Revenues  65,106  60,439  138,579  119,845
         
Operating expenses        
Compensation and related expenses   38,508  34,060  81,208  71,840
Other operating expenses  5,704  5,388  11,486  10,607
Reimbursable expenses  4,533  5,311  13,823  9,516
General and administrative expenses   2,984  2,905  6,319  5,600
         
   51,729  47,664  112,836  97,563
Operating income   13,377  12,775  25,743  22,282
         
Other income         
Interest income, net  41  66  62  129
Miscellaneous income, net  542  (560)  1,534  400
   583  (494)  1,596  529
         
Income before income taxes  13,960  12,281  27,339  22,811
         
Income taxes  5,743  5,001  11,119  9,292
         
         
Net income   $ 8,217  $ 7,280  $ 16,220  $ 13,519
         
Net income per share:        
Basic  $ 0.57  $ 0.51  $ 1.12  $ 0.95
Diluted  $ 0.55  $ 0.48  $ 1.08  $ 0.90
         
Shares used in per share computations:        
Basic  14,402  14,377  14,467  14,295
Diluted  14,971  15,054  15,062  15,009
 
 
EXPONENT, INC.
CONDENSED CONSOLIDATED BALANCE SHEETS
July 1, 2011 and December 31, 2010
(unaudited)
(in thousands)
     
  July 1,
2011
December 31,
2010
Assets    
Current assets:    
Cash and cash equivalents  $ 69,453  $ 106,549
Short-term investments  25,569  -- 
Accounts receivable, net  76,737  72,034
Prepaid expenses and other assets  7,860  10,585
Deferred income taxes  7,195  5,426
Total current assets  186,814  194,594
Property, equipment and leasehold improvements, net  27,731  27,267
Goodwill  8,607  8,607
Other assets  33,673  28,424
   $ 256,825  $ 258,892
     
Liabilities and Stockholders' Equity    
Current liabilities:    
Accounts payable and accrued liabilities  $ 8,847  $ 9,715
Accrued payroll and employee benefits  36,235  41,888
Deferred revenues  4,831  6,131
Total current liabilities  49,913  57,734
Other liabilities  20,228  15,481
Deferred rent  2,016  1,877
Total liabilities  72,157  75,092
     
Stockholders' equity:    
Common stock  16  16
Additional paid-in capital  106,090  96,089
Accumulated other comprehensive loss  (131)  (451)
Retained earnings  163,717  156,086
Treasury stock, at cost  (85,024)  (67,940)
Total stockholders' equity  184,668  183,800
   $ 256,825  $ 258,892
 
 
EXPONENT, INC. 
EBITDA and EBITDAS (1) 
For the Quarters Ended July 1, 2011 and July 2, 2010
(unaudited)
(in thousands)
         
         
   Quarter Ended   Six Months Ended 
  July 1,
2011
July 2,
2010
July 1,
2011
July 2,
2010
         
Net Income  $ 8,217  $ 7,280  $ 16,220  $ 13,519
         
Add back (subtract):        
         
Income taxes  5,743  5,001  11,119  9,292
Interest income, net  (41)  (66)  (62)  (129)
Depreciation and amortization  1,068  1,078  2,132  2,151
         
EBITDA (1)  14,987  13,293  29,409  24,833
         
Stock-based compensation  2,119  2,001  5,934  5,093
         
EBITDAS (1)  $ 17,106  $ 15,294  $ 35,343  $ 29,926
         
(1) EBITDA is a non-GAAP financial measure defined by the Company as net income before income taxes, interest
income, depreciation and amortization. EBITDAS is a non-GAAP financial measure defined by the Company as
EBITDA before stock-based compensation. The Company regards EBITDA and EBITDAS as useful measures of
operating performance and cash flow to compliment operating income, net income and other GAAP financial
performance measures. Additionally, management believes that EBITDA and EBITDAS provide meaningful
comparisons of past, present and future operating results. Generally, a non-GAAP financial measure is a numerical
measure of a company's performance, financial position or cash flow that either excludes or includes amounts that are not
normally excluded or included in the most directly comparable measure calculated and presented in accordance with
GAAP. These measures, however, should be considered in addition to, and not as a substitute or superior to, operating
income, cash flows, or other measures of financial performance prepared in accordance with GAAP.
CONTACT: Exponent
         (888) 656-EXPO
         info@exponent.com
         www.exponent.com